BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee S, Kim OJ, Lee KO, Jung H, Oh SH, Kim NK. Enhancing the Therapeutic Potential of CCL2-Overexpressing Mesenchymal Stem Cells in Acute Stroke. Int J Mol Sci 2020;21:E7795. [PMID: 33096826 DOI: 10.3390/ijms21207795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhou H, He Y, Xiong W, Jing S, Duan X, Huang Z, Nahal GS, Peng Y, Li M, Zhu Y, Ye Q. MSC based gene delivery methods and strategies improve the therapeutic efficacy of neurological diseases. Bioactive Materials 2023;23:409-437. [DOI: 10.1016/j.bioactmat.2022.11.007] [Reference Citation Analysis]
2 Lin YT, Chen HD, Ai QD, Yang YT, Zhang Z, Chu SF, Chen NH. Characteristics and pathogenesis of chemokines in the post-stroke stage. Int Immunopharmacol 2023;116:109781. [PMID: 36720195 DOI: 10.1016/j.intimp.2023.109781] [Reference Citation Analysis]
3 Cherkashova EA, Namestnikova DD, Gubskiy IL, Revkova VA, Sukhinich KK, Melnikov PA, Abakumov MA, Savina GD, Chekhonin VP, Gubsky LV, Yarygin KN. Dynamic MRI of the Mesenchymal Stem Cells Distribution during Intravenous Transplantation in a Rat Model of Ischemic Stroke. Life 2023;13:288. [DOI: 10.3390/life13020288] [Reference Citation Analysis]
4 Thankam FG, Sedighim S, Kuan R, Agrawal DK. Ischemia challenged epicardial adipose tissue stem cells-derived extracellular vesicles alter the gene expression of cardiac fibroblasts to cardiomyocyte like phenotype. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.10.004] [Reference Citation Analysis]
5 Zhang Y, Liu L, Zhao X, Yan S, Zeng F, Zhou D. New insight into ischemic stroke: Circadian rhythm in post-stroke angiogenesis. Front Pharmacol 2022;13:927506. [DOI: 10.3389/fphar.2022.927506] [Reference Citation Analysis]
6 Yang Y, Zhao RC, Zhang F. Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives. Front Cell Dev Biol 2022;10:933565. [DOI: 10.3389/fcell.2022.933565] [Reference Citation Analysis]
7 Soares MBP, Gonçalves RGJ, Vasques JF, da Silva-junior AJ, Gubert F, Santos GC, de Santana TA, Almeida Sampaio GL, Silva DN, Dominici M, Mendez-otero R. Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases. Front Mol Neurosci 2022;15:883378. [DOI: 10.3389/fnmol.2022.883378] [Reference Citation Analysis]
8 Ma Z, Chu L, Liu C, Liu W, Wei J, Xu Y. Construction of a Joint Prediction Model for the Occurrence of Ischemic Stroke and Acute Myocardial Infarction Based on Bioinformatic Analysis. Disease Markers 2022;2022:1-14. [DOI: 10.1155/2022/5967131] [Reference Citation Analysis]
9 Geng H, Chen L, Tang J, Chen Y, Wang L. The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials. Int J Mol Sci 2022;23:3485. [PMID: 35408846 DOI: 10.3390/ijms23073485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang Y, Dong N, Hong H, Qi J, Zhang S, Wang J. Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke. Int J Mol Sci 2022;23:2550. [PMID: 35269692 DOI: 10.3390/ijms23052550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Hirakawa MP, Tjahjono N, Light YK, Celebi AN, Celebi NN, Chintalapudi P, Butler KS, Branda SS, Krishnakumar R. Upregulation of CD14 in mesenchymal stromal cells accelerates lipopolysaccharide-induced response and enhances antibacterial properties. iScience 2022;25:103759. [PMID: 35141503 DOI: 10.1016/j.isci.2022.103759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kulesza A, Zielniok K, Hawryluk J, Paczek L, Burdzinska A. Ibuprofen in Therapeutic Concentrations Affects the Secretion of Human Bone Marrow Mesenchymal Stromal Cells, but Not Their Proliferative and Migratory Capacity. Biomolecules 2022;12:287. [DOI: 10.3390/biom12020287] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jeong H, Kim OJ, Oh SH, Lee S, Reum Lee HA, Lee KO, Lee BY, Kim NK. Extracellular Vesicles Released from Neprilysin Gene-Modified Human Umbilical Cord-Derived Mesenchymal Stem Cell Enhance Therapeutic Effects in an Alzheimer's Disease Animal Model. Stem Cells Int 2021;2021:5548630. [PMID: 34899919 DOI: 10.1155/2021/5548630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Zhu Z, Guo L, Yeltai N, Xu H, Zhang Y. Chemokine (C-C motif) ligand 2-enhanced adipogenesis and angiogenesis of human adipose-derived stem cell and human umbilical vein endothelial cell co-culture system in adipose tissue engineering. J Tissue Eng Regen Med 2021. [PMID: 34811942 DOI: 10.1002/term.3264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hurd MD, Goel I, Sakai Y, Teramura Y. Current status of ischemic stroke treatment: From thrombolysis to potential regenerative medicine. Regen Ther 2021;18:408-17. [PMID: 34722837 DOI: 10.1016/j.reth.2021.09.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
16 da Costa VR, Araldi RP, Vigerelli H, D'Ámelio F, Mendes TB, Gonzaga V, Policíquio B, Colozza-Gama GA, Valverde CW, Kerkis I. Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications. Cells 2021;10:2617. [PMID: 34685596 DOI: 10.3390/cells10102617] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
17 Guo Y, Peng Y, Zeng H, Chen G. Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke. Stem Cells Int 2021;2021:9923566. [PMID: 34221026 DOI: 10.1155/2021/9923566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
18 Bogensperger C, Hofmann J, Messner F, Resch T, Meszaros A, Cardini B, Weissenbacher A, Oberhuber R, Troppmair J, Öfner D, Schneeberger S, Hautz T. Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs. Int J Mol Sci 2021;22:5233. [PMID: 34063399 DOI: 10.3390/ijms22105233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhu H, Zhang Y, Zhong Y, Ye Y, Hu X, Gu L, Xiong X. Inflammation-Mediated Angiogenesis in Ischemic Stroke. Front Cell Neurosci 2021;15:652647. [PMID: 33967696 DOI: 10.3389/fncel.2021.652647] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
20 Zhou G, Wang Y, Gao S, Fu X, Cao Y, Peng Y, Zhuang J, Hu J, Shao A, Wang L. Potential Mechanisms and Perspectives in Ischemic Stroke Treatment Using Stem Cell Therapies. Front Cell Dev Biol 2021;9:646927. [PMID: 33869200 DOI: 10.3389/fcell.2021.646927] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
21 He J, Liu J, Huang Y, Tang X, Xiao H, Hu Z. Oxidative Stress, Inflammation, and Autophagy: Potential Targets of Mesenchymal Stem Cells-Based Therapies in Ischemic Stroke. Front Neurosci 2021;15:641157. [PMID: 33716657 DOI: 10.3389/fnins.2021.641157] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
22 Zhou T, Yuan Z, Weng J, Pei D, Du X, He C, Lai P. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14:24. [PMID: 33579329 DOI: 10.1186/s13045-021-01037-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 72] [Article Influence: 31.0] [Reference Citation Analysis]